Femasys Inc
FEMY
Detailliertes Diagramm anzeigen
0.835USD
+0.151+22.17%
Handelsschluss 11/05, 16:00（ET）Kurse um 15 Minuten verzögert
27.20MMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+22.17%
5 Tage
+32.67%
1 Monat
+32.52%
6 Monate
-29.24%
Seit Jahresbeginn
-24.09%
1 Jahr
-30.42%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Femasys Inc
Währung: USD Aktualisiert: 2025-11-04Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ stabil. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Kaufen bewertet. Trotz einer guten Aktienmarktperformance und starker technischer Indikatoren unterstützen die Fundamentaldaten den aktuellen Trend nicht. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Femasys Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
3
Analysten
Kaufen
Aktuelles Rating
5.667
Kursziel
+762.38%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Femasys Inc Highlights
HöhepunkteRisiko
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
performance_growth_high
performance_growth_high_desc%!(EXTRA string=35.06%)
performance_growth_period
performance_growth_period_desc%!(EXTRA string=1.63M)
high_profit_growth
high_profit_growth_desc%!(EXTRA string=1.63M)
valuation_overestimated
valuation_overestimated_desc%!(EXTRA string=PE, string=-0.80)
institutional_increasing_position
institutional_increasing_position_desc%!(EXTRA string=6.07M, string=18.36%)
institutional_hold%!(EXTRA string=The Vanguard)
institutional_hold_desc%!(EXTRA string=The Vanguard, string=951.87K)
activity_increase
activity_increase_desc%!(EXTRA string=0.15)
Femasys Inc Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Femasys Inc Informationen
Femasys Inc. is a biomedical company. The Company is focused on addressing unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. The Company also developed a technology platform, namely FemEMB for tissue sampling intended to be marketed alongside its other women-specific medical products in the physician’s office setting.
BörsenkürzelFEMY
UnternehmenFemasys Inc
CEOMs. Kathy Lee-Sepsick
Websitehttps://www.femasys.com/
Verwandte Finanzinstrumente
-0.93%
-1.00%
+0.42%
+1.81%
-0.76%
+0.06%
-1.36%
-0.02%
+0.32%
+0.60%
+0.46%
-1.92%
+2.75%
-0.26%
-1.48%
-1.56%
+0.60%
+0.47%
+0.20%
-0.48%Beliebte Symbole
